TherapeuticsMD Inc (TXMD.A) Quote| Reuters.com
Edition:
United States

TherapeuticsMD Inc (TXMD.A)

TXMD.A on American Stock Exchange

8.32USD
24 Jun 2016
Change (% chg)

$-0.53 (-5.99%)
Prev Close
$8.85
Open
$8.41
Day's High
$8.67
Day's Low
$8.25
Volume
652,299
Avg. Vol
189,846
52-wk High
$11.26
52-wk Low
$5.19

TXMD.A

Chart for TXMD.A

About

TherapeuticsMD, Inc. is a women's healthcare product company. The Company's segment is creating and commercializing products for women. It is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. Its drug candidates are created using its... (more)

Overall

Beta: 0.51
Market Cap(Mil.): $1,632.91
Shares Outstanding(Mil.): 196.26
Dividend: --
Yield (%): --

Financials

  TXMD.A Industry Sector
P/E (TTM): -- 32.69 34.11
EPS (TTM): -0.47 -- --
ROI: -62.64 15.00 14.23
ROE: -62.79 16.08 15.46

BRIEF-TherapeuticsMD Q1 loss per share $0.11

* TherapeuticsMD announces first quarter 2016 financial results

May 03 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Jefferson Research
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.